首页> 外国专利> PET/CT TRACER HAVING SELECTIVITY FOR DIFFERENT LUNG CANCER CELLS, PREPARATION METHOD THEREFOR AND USE THEREOF

PET/CT TRACER HAVING SELECTIVITY FOR DIFFERENT LUNG CANCER CELLS, PREPARATION METHOD THEREFOR AND USE THEREOF

机译:具有不同肺癌细胞的选择性的PET / CT示踪剂,其制备方法及其用途

摘要

A PET/CT tracer having selectivity for different lung cancer cells, a preparation method therefor and use thereof. The PET/CT tracer is a compound represented by formula I, or a salt or stereoisomer thereof, wherein R1 and R2 are each independently selected from H or C1-C5 alkyl, and X is independently selected from 11C, 18F, 19F, 15O, or 13N. The prepared 18F-PET/CT tracer can be selectively taken in by different carcinogenic driver gene mutant lung cancer cells. Test results show that the 18F-PET/CT tracer is expected to achieve high quality imaging in an NRas Q61K tumor model, and has certain selectivity for different carcinogenic driver gene mutant lung cancers. The tracer is different from 18F-FDG that may lead to high-concentration imaging in any lesion due to increased glucose metabolism, and is expected to make up for the deficiency of imaging by using 18F-FDG alone. Therefore, the 18F-PET/CT tracer is expected to be applied to PET/CT iconography and change the situation of lack of tracers on lung cancers.
机译:具有不同肺癌细胞的选择性的PET / CT示踪剂,其制备方法及其用途。 PET / CT示踪剂是由式I代表的化合物,或其盐或立体异构体,其中R 1 和R 2 各自独立地选自H或C 1 -C 5 烷基,x独立地选自 11℃, 18-sup> f, 19 f, 15 o,或 13 n。制备的 18-sup> f-pet / ct示踪剂可以通过不同的致癌驾驶员基因突变体肺癌细胞选择性地吸收。测试结果表明,预期 18 f-pet / ct示踪剂在NRAS Q61K肿瘤模型中实现高质量的成像,并对不同的致癌驾驶员基因突变体肺癌具有一定的选择性。示踪剂与 18 f-fdg不同,其可能导致任何血糖代谢引起的任何病变中的高浓度成像,并且预期通过使用 18来弥补成像的缺陷单独的 F-FDG。因此,预期 18 F-PET / CT示踪剂将应用于PET / CT ICONOMING,并改变肺癌上缺乏示踪剂的情况。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号